# OnCo record nct07779798 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07779798/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07779798", "NCT07779798" ;
  schema:name "A Phase 1, Open-Label, Dose-Escalation Study to Evaluate Safety, Tolerability, and Clinical Activity of CBX-663 in Participants With Relapsed or Refractory Myeloid Malignancies, Advanced Solid Tumors, or Recurrent or Progressive Glioblastoma."@en ;
  schema:description "A phase 1 trial of CBX-663 run by Crossbow Therapeutics, Inc., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07779798/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07779798> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/>, <https://onco.cc/cancers/glioblastoma/>, <https://onco.cc/cancers/leukaemia/> ;
  onco:drugs <https://onco.cc/drugs/cbx-663/> ;
  onco:companies <https://onco.cc/companies/crossbow-therapeutics/> .